Allogene CFO Geoffrey Parker to retire effective Nov. 6
Allogene Therapeutics said CFO Geoffrey Parker will retire effective Nov. 6, adding to leadership changes after Zachary Roberts was elevated to chief executive.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.